Remix Therapeutics
Our Science
Platform
Pipeline
REM-422
About Us
Our Story
Our People
Our Investors
Our Partners
Join Us
News
News
Press Releases
Publications
Clinical Trials
Our Science
Platform
Pipeline
REM-422
About Us
Our Story
Our People
Our Investors
Our Partners
Join Us
News
News
Press Releases
Publications
Clinical Trials
Contact
Aug | 20 | 2025
Publication
Identification of Selective Small Molecule Modulators of mRNA Processing Using a Multiplexed QuantiGene High-Throughput Screening Platform
Mary Ann Liebert
A Part of Sage
Read Article
Back to News
Media Contact
media@remixtx.com
Investor Contact
WILL O’CONNOR
Precision AQ
Will.OConnor@precisionaq.com